International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

 

Recommended Conferences for Emerging Infectious Diseases

Emerging Infectious Diseases


As per available reports about 66 relevant journals, 15 Conferences, 1395 workshops are presently dedicated exclusively to breathing disorder and about 3040 articles are being published on Infectious Diseases.

An Emerging Infectious Disease (EID) is an infectious disease whose incidence has increased in the past 35 years and could increase in the near future. Emerging infections account for at least 12% of all human pathogens. EIDs are caused by newly identified species or strains (e.g. SARS, AIDS) that may have evolved from a known infection (e.g. influenza) or spread to a new population (e.g. West Nile virus) or area undergoing ecologic transformation (e.g. Lyme disease) or be re emerging infections like drug resistant tuberculosis. Of growing concern are adverse synergistic interactions between emerging diseases and other infectious and non infectious conditions leading to the development of novel syndemics.

OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.

Scope and Importance

The following factors contributing to Emerging Infectious Diseases

1. Changing human susceptibility for e.g. mass immunecompromisation with HIV/ AIDS

2. Microbial adaption for e.g. genetic drift and genetic shift in Influenza A

3. Climate and weather for e.g. diseases with zoonotic vectors such as West Nile Disease

(transmitted by mosquitoes) are moving further from the tropics as the climate warms

4. Change in human demographics and trade for e.g. rapid travel enabled SARS to rapidly propagate around the globe

5. Economic development for e.g. use of antibiotics to increase meat yield of farmed cows leads to antibiotic resistance

6. Breakdown of public health for e.g. the current situation in Zimbabwe

7. Poverty and social inequality for e.g. tuberculosis is primarily a problem in low-income areas

8. War and famine

9. Bioterrorism for e.g. 2001 Anthrax attacks

10. Dam and irrigation system construction for e.g. malaria and other mosquito borne diseases

 

The following are the additional Emerging Infectious Diseases/ Pathogens

 Acanthamebiasis

 Anaplasmosis (new in FY14)

 Aspergillus (new in FY14)

 Australian bat lyssavirus

 Babesia, atypical

 Bartonella henselae

 BK virus (new in FY14)

 Borrelia miyamotoi (new in FY14)

 Clostridium difficile

 Cryptococcus gattii (new in FY14)

 Ehrlichiosis

 Enterococcus faecium and faecalis (new in FY14)

 Enterovirus 71

 Hepatitis C (new in FY14)

 Hepatitis E (new in FY14)

 Human herpesvirus 8

 Human herpesvirus 6

 JC virus (new in FY14)

 Leptospirosis (new in FY14)

 Lyme borreliosis

 Mucormycosis (new in FY14)

 Mumps virus

 Rubeola (measles) (new in FY14)

 Streptococcus, Group A

 Staphylococcus aureus

 

Market Analysis

Infectious diseases therapeutic market

The infectious diseases therapeutic market in US is estimated to grow at a rate of 3.37% between 2014- 2019. As per the records, 25% of deaths are mainly due to infectious diseases globally. Current market trend shows that North America has the more global market for infectious diseases therapeutics due to increasing incidence of infectious diseases and due to rise in aging population. Followed by North America highest global market is expected in Asia then followed by the Europe in the global infectious diseases therapeutics market. In Asia-Pacific region, China and India are expected to be the fastest growing infectious diseases therapeutics markets. The main reasons behind the highest global market of infectious diseases therapeutics market in the above countries is mainly due to large number of patients and due to increase in government funding. Some of the major companies playing a key role in the global infectious diseases therapeutics market are Merck & Co., Pfizer, Johnson & Johnson, F. Hoffmann-La Roche, GlaxoSmithKline Pharmaceutical, Inc., Auritec Pharmaceuticals, Novartis, Achillion Pharmaceuticals, Isis Pharmaceuticals and Gilead Sciences.

Infectious diseases diagnostics market

Market for infectious disease molecular diagnostics tests includes hospitals, blood banks, reference laboratories. North America has the highest global market for molecular diagnostics tests followed by Europe due to the market availability of the tests and high occurrence rate of various infectious diseases such as HPV, hepatitis and bacterial infections. Asia Pacific, Latin America and Middle East are expected to be the potential markets in the coming years. Major companies which play a key role in infectious disease molecular diagnostics tests market are Abbott Laboratories, Affymetrix, Inc., Becton, Dickinson and Company, bioMérieux, Cepheid, Inc., Hologic, Inc., Life Technologies, Myriad Genetics, Inc., Qiagen N.V. and others.

List of Best International Conferences

1. 2nd Infectious Diseases Conference 

    Aug 25-27, 2016 Philadelphia, USA

2. Rare Diseases and Orphan Drugs Conference

    May 12-13, 2016 Chicago, USA

3. Infection Prevention and Control Conference

    Aug 1-2, 2016 Frankfurt, Germany

4. Human Papillomavirus Conference

    May 2-3, 2016 Chicago, USA

5. Lupus Conference

    Oct 27-28, 2016 Chicago, USA

6. Allergy Conference

    March 29-30, 2016 Valencia, Spain

7. Mycology Conference

    Sept 12-14, 2016 San Antonio, USA

8. Medical Parasitology Conference

    Oct 17-19, 2016 Houston, USA

9. 4th HIV/AIDS, STDs and STIs Conference

    Oct 3-5, 2016, Miami, USA

10. 5th Virology Conference

      Dec 1-3, 2016, Baltimore, USA

11. 2nd Influenza Conference

      Sept 12-14, 2016 Berlin, Germany

12. 2nd Parasitology Conference

      Oct 10-12, 2016 Manchester, UK

13. 6th Euro Virology Conference

      March 10-12, 2016 Madrid, Spain

14. 3rd Hepatitis and Liver Diseases Conference

      Oct 17-19, 2016 Dubai, UAE

15. 4th Epidemiology and Emerging Diseases Conference

      Oct 3-5, 2016 London, UK

16. 2nd Flu Conference

      Nov 17-19, 2016 San Francisco, USA

17. 3rd Chronic Obstructive Pulmonary Disease (COPD) Conference

      July 11-12, 2016 Brisbane, Australia

18. European Infectious Diseases Conference

      Aug 1-3, 2016 Frankfurt, Germany

19. 4th Bacteriology and Infectious Diseases Conference

      May 16-18, 2016 San Antonio, USA

20. Infectious Diseases and Diagnostic Microbiology Conference

      Oct 3-5, 2016 Vancouver, Canada

21. 2nd Retroviruses and Novel Drugs Conference

      June 30-Jul 1, 2016 Capetown, South Africa

22. 72nd Allergy, Asthma and Immunology Conference

      San Antonio, USA

23. European Clinical Microbiology and Infectious Diseases Conference

      Istanbul, Turkey

24. Infection Prevention and Control Conference

      Tübingen, Germany

25. 17th Infectious Diseases Conference

      Hyderabad, India

26. 34th Annual Infectious Diseases Conference

      Sacramento, California

 

Relevant Societies and Associations

1. Infectious Diseases Society of America

2. German Centre for Infection Research

3. International Society of Infectious diseases

4. Australasian Society for Infectious Diseases

5. Infectious disease association of California

6. European Society of Clinical Microbiology and Infectious Diseases

7. British Infection Association

8. Society of Tropical Medicine & Infectious Diseases in India

9. Clinical Infectious Diseases Society in India

10. Pediatric Infectious Diseases Society

 

Major Companies

1. Pfizer

2. Novartis

3. Sanofi

4. Roche Holding

5. Merck & Co

6. GlaxoSmithKline

7. AstraZeneca

8. Eli Lilly & Co

9. Abbott Laboratories

10. McKesson

11. Allergan

12. The Native Antigen Company

This page will be updated regularly.

This page was last updated on March 19, 2024

Conference Series Destinations